- Stocks
- Pages
- Blogs
- Research Reports
Portfolio Management Services

View

Investment Banking

View

Institutional Equities

View

Wealth Management

View

Loans

View

DIY Investing & Trading

View

What is a Demat Account? Meaning, Benefits, Types & How It Works
4 September 2026
Read Blog

What is Mutual Fund: Definition, Benefits & How to Invest in it 
3 September 2026
Read Blog

What is an IPO? Full Form, Meaning & How It Works
2 September 2026
Read Blog

Portfolio Allocation Strategy During Interest Rate Cycles
30 June 2026
Read Blog

What happens after a company gets delisted?
19 June 2026
Read Blog

FII vs DII: Key Differences Explained
16 June 2026
Read Blog

What Is REIT?
15 June 2026
Read Blog

Difference Between Bull and Bear Market
12 June 2026
Read Blog

What is IOC in Share Market?
11 June 2026
Read Blog

What Is a Short Delivery in Share Market?
10 June 2026
Read Blog

View All Blogs

PSP Projects (PSPPL IN) – Q2FY27 Result Update – Execution-led beat; attractive risk reward – Upgrade to ‘BUY’
03 November 2026
Read Report

ITC (ITC IN) – Q2FY27 Result Update – Worst seems over, expect gradual recovery – Upgrade to ‘ACCUMULATE’
02 November 2026
Read Report

Marico (MRCO IN) – Q2FY27 Result Update – Strong growth outlook despite macro headwinds – Upgrade to ‘BUY’
02 November 2026
Read Report

Mold-tek Packaging (MTEP IN) – Q2FY27 Result Update – Healthy demand outlook, improving mix to drive growth – ACCUMULATE
02 November 2026
Read Report

LIC Housing Finance (LICHF IN) – Q2FY27 Result Update – Growth and margin pressure persists – HOLD
02 November 2026
Read Report

The Beat – DCX Systems set for a booming upside!
02 January 2025
Read Report

Aarti Industries (ARTO IN) – Q2FY27 Result Update – Zone IV expansion to drive growth – ACCUMULATE
02 November 2026
Read Report

JSW Steel (JSTL IN) – Q3FY25 Result Update – Better quarter, but HRC situation yet to improve – HOLD
27 January 2025
Read Report

Technical Newsletter: 2-Nov-2026
02 November 2026
Read Report

ICICI Bank (ICICIBC IN) – Q3FY25 Result Update – Asset quality remains best-in-class – BUY
27 January 2025
Read Report

View All Reports
Login
Open Account

Venmax Drugs & Pharmaceuticals Ltd

Q: What is the current share price of Venmax Drugs & Pharmaceuticals Ltd?

As of 03-Nov-2026, 12:58:27 the share price for Venmax Drugs & Pharmaceuticals Ltd. is ₹ 13.73 on the NSE (Note: Prices are dynamic and update frequently during market hours).

Small Cap | Pharmaceuticals

₹ 13.73 0.09(0.66%)

Last updated: 03-Nov-2026 , 12:58:27

Venmax Drugs & Pharmaceuticals Ltd Price Today Venmax Drugs & Pharmaceuticals Ltd share price is ₹13.73 as on 03-Nov-2026, Up 0.66% from the previous close of ₹13.64. The stock has traded between ₹14.45 and ₹13.02 today, against a 52-week range of ₹12.51 to ₹31.49. Over the past year the stock is Down 151.72% range. Market capitalisation stands at ₹21.57 crore.

Venmax Drugs & Pharmaceuticals Ltd Live Price Chart

Fundamental
Performance
Financials
Share Holding Pattern
About Company

Performance

Low: ₹13.02 High: 14.45

Previous Close	₹ 13.64
High	₹ 14.45
Volume	1148
52W Range	₹ 12.51 - ₹ 31.49

Open	₹ 13.99
Low	₹ 13.02
Market Cap	₹ 21.57 Cr

Venmax Drugs & Pharmaceuticals Ltd Technicals

Current Price

₹ 13.73 0.09 (0.66%)

EMASMA

20 Day	₹ 14.131
50 Day	₹ 14.977
100 Day	₹ 16.708
200 Day	₹ 19.163

20 Day	₹ 14.231
50 Day	₹ 14.694
100 Day	₹ 16.401
200 Day	₹ 20.711

Venmax Drugs & Pharmaceuticals Ltd Fundamentals

ROCE	2.034
P/E Ratio	71.790
P/B Ratio	0.950
Industry P/E	0.950
Debt to Equity	49.694

ROE	1.868
EPS	0.190
Dividend Yield	0.000
Book Value	14.368
Face Value	10.000

Venmax Drugs & Pharmaceuticals Ltd Financials

Particulars	Y202603	Y202503	Y202403	Y202303	Y202203
Total Revenue	8.1853	1.8605	0.1986	0.4193	1.983
Total Expenses	7.9083	1.8746	0.1117	0.1936	0.1364
Profit After Tax	0.2482	-0.0105	0.0645	0.2256	1.8463

Venmax Drugs & Pharmaceuticals Ltd Shareholding Pattern

Promoter Holdings	10.464 %
FIIs	0.000 %
DIIs	0.000 %
MutualFund	0.000 %
Retail	75.662 %
Others -	13.874 %

About Venmax Drugs & Pharmaceuticals Ltd

Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Company as 'Yenkay Medico Private Limited', on 28 September, 1998. The Company thereafter changed its name to 'Yenkey Drugs & Pharmaceuticals Private Limited' on 18 January, 1995. It became a Public Limited Company on February 3, 1995 as 'Yenkey Drugs & Pharmaceuticals Limited'. Finally, the Company changed its name to 'Venmax Drugs & Pharmaceuticals Limited' on April 13, 2009. For the past six months, Company focused on establishing chain of Medical Stores with a brand name as 'Ananya Pharma' under the Venmax Drugs & Pharma Limited, with the backing support of Formulations plant (Suzichem Labs). At present, Company is engaged in the business of pharmaceutical products, drug intermediaries & API's etc. The Company is developing the oncology products in R&D. Planning to establish a manufacturing UNIT with cGMP facility at Pharma Cluster at Hyderabad, to meet the export demand. ...

Similar Stocks

Ambalal Sarabhai Enterprises Ltd Pharmaceuticals	₹ 35.26 +0.46 (+1.32%)
Amrutanjan Health Care Ltd Pharmaceuticals	₹ 499.60 +2.45 (+0.49%)
Astrazeneca Pharma India Ltd Pharmaceuticals	₹ 6,327.15 +43.9 (+0.7%)
Bliss GVS Pharma Ltd Pharmaceuticals	₹ 632.15 +15.5 (+2.51%)
Abbott India Ltd Pharmaceuticals	₹ 25,900.70 +117.2 (+0.45%)
Cipla Ltd Pharmaceuticals	₹ 1,383.90 +1.9 (+0.14%)

FAQs on Venmax Drugs & Pharmaceuticals Ltd

1. Can I buy Venmax Drugs & Pharmaceuticals Ltd from PL Capital? ›

Yes, you can invest in Venmax Drugs & Pharmaceuticals Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Venmax Drugs & Pharmaceuticals Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Venmax Drugs & Pharmaceuticals Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.

2. Does Venmax Drugs & Pharmaceuticals Ltd pay dividends? ›

Venmax Drugs & Pharmaceuticals Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.

3. What is the current share price of Venmax Drugs & Pharmaceuticals Ltd ? ›

As of 03-Nov-2026 , 12:58:27 the share price for Venmax Drugs & Pharmaceuticals Ltd. is ₹ 13.73 on the NSE (Note: Prices are dynamic and update frequently during market hours).

4. What is the 52-week high and low of Venmax Drugs & Pharmaceuticals Ltd ? ›

The 52-week high and low of Venmax Drugs & Pharmaceuticals Ltd share price is ₹ 12.51 - ₹ 31.49 as of 03-Nov-2026 , 12:58:27 .

5. What is the market capitalisation of Venmax Drugs & Pharmaceuticals Ltd? ›

Market capitalisation of Venmax Drugs & Pharmaceuticals Ltd is ₹21.57Cr as of 03-Nov-2026.

6. What is the current P/E ratio of Venmax Drugs & Pharmaceuticals Ltd? ›

The P/E (price-to-earnings) ratio of Venmax Drugs & Pharmaceuticals Ltd is 71.790.

7. What is the current P/B ratio of Venmax Drugs & Pharmaceuticals Ltd? ›

The P/B (price-to-book) ratio of Venmax Drugs & Pharmaceuticals Ltd is 0.950.

8. What is the shareholding pattern of Venmax Drugs & Pharmaceuticals Ltd? ›

As of 03-Nov-2026, promoters hold 10.464%, foreign institutional investors hold 0.000%, domestic institutional investors hold 0.000%, and the public holds 75.662%.